Article info
PDFHepatology
Original article
High risk of hepatocellular carcinoma and death in patients with immune-tolerant-phase chronic hepatitis B
- Correspondence to Professor Young-Suk Lim, Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Songpa-gu, Seoul 138-736, Korea; limys{at}amc.seoul.kr
Citation
High risk of hepatocellular carcinoma and death in patients with immune-tolerant-phase chronic hepatitis B
Publication history
- Received July 22, 2017
- Revised September 5, 2017
- Accepted September 26, 2017
- First published October 21, 2017.
Online issue publication
March 06, 2019
Article Versions
- Previous version (6 March 2019).
- Previous version (6 March 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.